Cargando…
Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays
Gender-affirming hormonal therapies are a critical component of the care of transgender individuals. Transgender people are commonly prescribed estrogen or testosterone to promote male-to-female or female-to-male transitions and to preserve gender-specific characteristics long-term. However, some ex...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562871/ https://www.ncbi.nlm.nih.gov/pubmed/37822706 http://dx.doi.org/10.1016/j.rpth.2023.102197 |